Seoul

Running trials

• Recruiting

  A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder

  NCT07475806· Phase 2· Source

• Recruiting

  A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.

  NCT06902545· Source

• Recruiting

  A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection

  NCT06011954· Source

• Active, not recruiting

  A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.

  NCT03504397· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer2 recruiting
• Childhood cancers2 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) Mutation

  NCT04691648· Source